Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 38 (RPL23AP38)
- Target
- RPL23AP38
- Molecular classification
- Other (Pseudogene), Non-coding RNA (Pseudogene of a ribosomal protein gene)
01
Overview
Ribosomal protein L23a pseudogene 38 (RPL23AP38) is a processed pseudogene related to the protein-coding RPL23A gene, which codes for a structural component of the 60S subunit of the ribosome. Like other ribosomal protein pseudogenes, RPL23AP38 is not known to encode a functional protein, nor is there evidence that it is transcribed or has a significant regulatory role. It is not considered a receptor, enzyme, transporter, or therapeutic molecular target. While some ribosomal protein pseudogenes (such as RPL23AP53) have demonstrated altered expression and biomarker potential in certain cancers, there is currently no information to support such a role for RPL23AP38 specifically.
- Other names
- RPL23AP38RPL23A_11_340
02
Mechanism of action
None
03
Biological functions
No direct biological function as it is a pseudogene(For the parent gene, RPL23A: component of the ribosome, rRNA binding, structural constituent of ribosome)
04
Disease associations
No established disease roles for this pseudogene specifically(Other ribosomal protein L23a pseudogenes, e.g. RPL23AP53, have been investigated for expression differences in cancer, such as melanoma, suggesting potential roles as biomarkers)
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
Pseudogenes from this family (analogous examples: RPL23AP53) have shown potential association with diagnosis and prognosis in cancers, e.g., *melanoma*, but not specifically for RPL23AP38
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 38 (RPL23AP38).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 38 (RPL23AP38).